FDA approves Medtronic’s drug-eluting stent, the smallest on the market

The FDA approved Medtronic’s Resolute Onyx drug-eluting stent Feb. 26 — making it the smallest drug-eluting stent on the U.S. market, according to the Star Tribune.

Advertisement

Here are three things to know.

1. The drug-eluting heart stent, Resolute Onyx 2.0 mm, is intended to treat blockages in tiny blood vessels.

2. Medtronic’s Resolute Onyx 2.0 mm stent, which is the smallest stent on the market in the U.S., joins its line of other Resolute Onyx stents that can treat coronary blood-vessel blockages.

3. The stent is coated with anti-inflammatory drugs that release into the blood vessel over time to prevent another blockage.

More articles on supply chain:
Why a better hospital supply chain starts with better relationships
Teva shutters offices in New York City, Washington D.C., as part of cost cutting plan
Walgreens, AmerisourceBergen reportedly end takeover discussions with no deal

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.